• Aminopeptidase Inhibition Modulates Angiotensin Signaling in

  2026-04-25

  Harding and Felix (1987) demonstrated that Bestatin hydrochloride enhances angiotensin II and III-evoked neuronal activity in the rat brain by inhibiting aminopeptidase B. Their findings clarify the enzymatic conversion of angiotensin II to III as a prerequisite for neural activation, and provide critical insight for research on neuropeptide regulation and enzymatic targeting.

• Ordered DNA Nanostructures Enhance Enzymatic DNA Synthesis E

  2026-04-24

  This study introduces a highly ordered tetrahedral DNA framework to address spatial hindrance and improve efficiency in enzymatic oligonucleotide synthesis (EOS). The approach significantly enhances enzyme accessibility and fidelity, supporting longer DNA synthesis and enabling accurate nucleic acid applications, such as DNA data storage.

• Protoporphyrin IX: Photodynamic Compound in Ferroptosis and

  2026-04-24

  Explore the dual role of Protoporphyrin IX as a photodynamic compound in cancer research and its central function in ferroptosis and heme formation. This article uniquely connects advanced mechanistic insights from recent hepatocellular carcinoma studies to practical laboratory applications.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Apoptosis Re

  2026-04-23

  Q-VD(OMe)-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) delivers potent, broad-spectrum caspase inhibition with minimal toxicity, setting a new benchmark for apoptosis and cell death assays. Its versatility and reproducibility empower researchers in cancer, neuroprotection, and mechanistic apoptosis studies.

• Topotecan (SKF104864): Precision Topoisomerase I Inhibition

  2026-04-23

  Topotecan (SKF104864) is a semi-synthetic camptothecin derivative that acts as a potent topoisomerase I inhibitor. It demonstrates broad-spectrum antitumor activity, including efficacy in recurrent small cell lung cancer (SCLC) and pediatric solid tumor models. Its mechanism and predictable toxicity profile make Topotecan a cornerstone tool in translational cancer research.

• Polymyxin B Sulfate: Precision Tool for Gram-Negative Infect

  2026-04-22

  Polymyxin B sulfate delivers reproducible, high-impact results in multidrug-resistant Gram-negative infection and immune modulation studies. This guide provides workflow-driven protocols, optimization strategies, and troubleshooting insights, leveraging APExBIO's rigorously benchmarked formulation.

• 6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I

  2026-04-22

  This study demonstrates that 6-thioguanine (6-TG) significantly inhibits EV71 replication in vitro by targeting BIRC3-mediated autophagy in human intestinal cells. The findings highlight a novel antiviral mechanism for 6-TG, suggesting translational potential for enteroviral therapeutics and providing a foundation for further mechanistic and preclinical research.

• Arachidonic Acid Supplementation Accelerates Vaccine-Induced

  2026-04-21

  This study demonstrates that dietary arachidonic acid (ARA) significantly enhances vaccine-induced neutralizing antibody production and protection against rabies infection in both mice and humans. Mechanistically, ARA is metabolized in lymph nodes to immune modulators such as prostaglandin I2, which upregulate B cell activation pathways, supporting its use as a dietary adjuvant for rapid and robust humoral immunity.

• Neticonazole Hydrochloride: Advanced Protocols in Oncology a

  2026-04-21

  Explore how Neticonazole Hydrochloride serves as an imidazole antifungal with unique dual roles in cutaneous candidiasis and colorectal cancer research. This article delivers practical assay guidance, mechanistic insights, and protocol parameters for translational scientists.

• D-Luciferin Potassium Salt: Elevating Bioluminescence Imagin

  2026-04-20

  D-Luciferin (potassium salt) delivers unmatched sensitivity and workflow efficiency for in vivo bioluminescence imaging and luciferase assays. APExBIO’s water-soluble formulation streamlines real-time tumor cell tracking and quantitative analysis, enabling breakthroughs in translational research.

• Dabigatran Etexilate: Advances in Oral Anticoagulation Thera

  2026-04-20

  This review examines the pharmacological innovation of dabigatran etexilate as the first oral direct thrombin inhibitor for prevention of stroke and venous thromboembolism. The study highlights its predictable pharmacokinetics and lack of CYP450 metabolism, marking a significant advance over traditional therapies and impacting the design of drug-drug interaction studies.

• A-769662: AMPK Activator for Advanced Metabolic Assays

  2026-04-19

  A-769662 stands out as a potent, reversible AMPK activator, enabling precise dissection of cellular energy regulation, fatty acid synthesis inhibition, and proteasome function. Its unique dual action and robust performance make it indispensable for metabolic disease and autophagy research.

• SP600125 as a JNK Inhibitor: Applied Workflows & Troubleshoo

  2026-04-18

  SP600125 stands out as a highly selective, ATP-competitive JNK inhibitor, enabling precise mapping of JNK-regulated pathways in apoptosis, inflammation, and cytokine expression modulation. This guide delivers actionable protocols, advanced troubleshooting, and real-world insights tailored for high-impact research applications.

• Substance P: Practical Guide for CNS & Inflammation Research

  2026-04-17

  Substance P (B6620) is a highly pure tachykinin neuropeptide widely used to model neurotransmission, pain signaling, and inflammation in preclinical research. This product is ideal for protocols requiring strict solubility, stability, and purity parameters but is not intended for diagnostic or medical use. Researchers should adhere closely to storage and handling guidelines to ensure experimental reproducibility.

• Renal K+ Channel Blockade Alters Vascular Response in Sepsis

  2026-04-16

  This study investigates how blocking specific potassium channels in the kidney modifies the organ's vascular response to vasopressors during sepsis. The findings reveal that ATP-sensitive and calcium-activated K+ channel inhibition, especially during early sepsis, can worsen renal blood flow reduction when combined with norepinephrine or phenylephrine, underscoring the complexity of vascular regulation in septic shock.

15203 records 1/1014 page Next 12345 下5页 Last page